News

"This strategy of short (3-months) dual antiplatelet therapy (ticagrelor plus aspirin) followed by ticagrelor monotherapy is associated with less bleeding without any compromise in ischemic events,” says PI Roxana Mehran, MD.

October 23, 2023– HOUMA, LA – Cardiovascular Institute of the South (CIS) is the first in the country to use the FreedomFlow® Orbital Atherectomy Platform to treat peripheral artery disease (PAD) in the legs. Drs. Pradeep Nair, McCall Walker,...

Overall, 92.9% survived after five years, and the eight-year survival was close to 90%.

St. Paul, MN – October 18, 2023. Cardio Flow, Inc., a privately held medical device company and developer of minimally invasive devices to treat peripheral artery disease (PAD), today announced it recently received U.S. Food and Drug...

The ProtEmbo System is an intra-aortic filter device that protects the entire brain from embolic material liberated during the TAVR procedure.

Two new publications reported excellent and consistent outcomes with coronary intravascular lithotripsy (IVL) in both nodular and eccentric calcium.

The EVOQUE system is comprised of a nitinol self-expanding frame, intra-annular sealing skirt, and tissue leaflets made from the same bovine pericardial tissue as the company's market-leading heart valves.

Most respondents reported that shortages have compromised patient care, with half saying shortages have delayed patient treatments and one-third reporting they were unable to provide patients with optimally recommended drugs or treatments.

Radial access for peripheral artery interventions was associated with favorable safety profiles.